INmune Bio, Inc. Data at ASH Highlight Innovative Natural Killer Cell Therapeutic Platform Showing 100+ Day Persistence of Cancer Killing Memory Like NK Cells in Patients with AML/MDS Following Treatment with INKmune(TM)
Stock Information for INmune Bio Inc.
Loading
Please wait while we load your information from QuoteMedia.